Compounds > transferrin
Page last updated: 2024-08-23

transferrin and Apolipoprotein B-100, Familial Defective

transferrin has been researched along with Apolipoprotein B-100, Familial Defective in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armstrong, VW; Bramlage, CP; Bramlage, P; Koziolek, MJ; Mueller, GA; Zapf, A1
Hirata, Y; Shichiri, M; Tanaka, A1
Paillard, F1
Battini, R; Borghi, S; Calandra, S; Croce, MA; Ferrari, S; Ghisellini, M; Parise, F; Simone, L; Tiozzo, R1
Cuthbert, JA; Lipsky, PE1
Muth, J; Shireman, RB; Toth, JP1

Trials

1 trial(s) available for transferrin and Apolipoprotein B-100, Familial Defective

ArticleYear
Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
    Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2010, Volume: 14, Issue:2

    Topics: Anemia; Blood Component Removal; Dyslipidemias; Erythropoiesis; Female; Ferritins; Filtration; Heparin; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a); Lipoproteins, LDL; Male; Middle Aged; Plasmapheresis; Transferrin; Vitamin B 12

2010

Other Studies

5 other study(ies) available for transferrin and Apolipoprotein B-100, Familial Defective

ArticleYear
Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
    Gene therapy, 2003, Volume: 10, Issue:9

    Topics: Animals; Cholesterol, LDL; Genetic Therapy; Hyperlipoproteinemia Type II; Injections, Intravenous; Leukocytes; Ligands; Liposomes; Rabbits; Receptors, LDL; RNA, Messenger; Transfection; Transferrin

2003
A novel soluble chimera for the treatment of familial hypercholesterolemia.
    Human gene therapy, 1999, May-01, Volume: 10, Issue:7

    Topics: Animals; Genetic Therapy; Humans; Hyperlipoproteinemia Type II; Rabbits; Receptors, LDL; Recombinant Fusion Proteins; Transferrin

1999
Construction and in vitro functional evaluation of a low-density lipoprotein receptor/transferrin fusion protein as a therapeutic tool for familial hypercholesterolemia.
    Human gene therapy, 1999, May-01, Volume: 10, Issue:7

    Topics: Animals; COS Cells; DNA, Complementary; Fibroblasts; Fluorescent Antibody Technique; Humans; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Plasmids; Precipitin Tests; Rabbits; Receptors, LDL; Recombinant Fusion Proteins; Transfection; Transferrin

1999
Lipoproteins may provide fatty acids necessary for human lymphocyte proliferation by both low density lipoprotein receptor-dependent and -independent mechanisms.
    The Journal of biological chemistry, 1989, Aug-15, Volume: 264, Issue:23

    Topics: Adult; Cells, Cultured; DNA Replication; Fatty Acids; Humans; Hyperlipoproteinemia Type II; Kinetics; Lipoproteins; Lymphocyte Activation; Lymphocytes; Receptors, LDL; Reference Values; Transferrin

1989
[14C]acetate incorporation by cultured normal, familial hypercholesterolemia and Down's syndrome fibroblasts.
    Biochimica et biophysica acta, 1988, Feb-19, Volume: 958, Issue:3

    Topics: Acetates; Acetic Acid; Carbon Radioisotopes; Cells, Cultured; Cholesterol; Down Syndrome; Fibroblasts; Gas Chromatography-Mass Spectrometry; Humans; Hyperlipoproteinemia Type II; Insulin; Leucine; Protein Biosynthesis; Receptors, LDL; Selenium; Transferrin

1988